Mechanisms of how Trypanosoma brucei TRF maintains telomere integrity

布氏锥虫 TRF 维持端粒完整性的机制

• 批准号: 10526882
• 负责人: Bibo Li
• 金额: $ 23.27万
• 依托单位: CLEVELAND STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-16 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10526882
• 关键词: Affect; Air; Antigenic Switching; Antigenic Variation; Atomic Force Microscopy; Automobile Driving; Binding; Biological Assay; Biology; Cells; Chromosomes; DNA; DNA Binding; DNA Damage; DNA Double Strand Break; DNA ligase I; Development; ERCC1 gene; Electrophoretic Mobility Shift Assay; Event; Exhibits; Frequencies; Future; Genes; Genetic; Genetic Recombination; Genetic Transcription; Homodimerization; Image; Immune response; Immunologics; In Vitro; Lead; Leishmania; Liquid substance; Mammals; Mediating; Membrane Glycoproteins; Molecular; Nonhomologous DNA End Joining; North Carolina; Nucleic Acids; Parasites; Parasitic infection; Pathogenesis; Pathway interactions; Play; Proteins; RNA; RNA Binding; RNA Interference; RNA Polymerase I; Rad51 recombinase; Role; Site; Southern Blotting; Speed; Structure; Surface Antigens; Testing; Trypanosoma brucei brucei; Trypanosoma cruzi; Universities; Variant; dimer; gel electrophoresis; homologous recombination; human disease; in vivo; knock-down; microscopic imaging; mutant; novel; novel therapeutics; pathogen; pathogenic microbe; rare variant; recombinase; recruit; single molecule; telomere; tool

Project Summary/Abstract Trypanosoma brucei, Trypanosoma cruzi, and Leishmania are closely related kinetoplastid parasites causing debilitating human diseases. T. brucei sequentially expresses immunologically distinct variant surface glycoproteins (VSGs), its major surface antigen, exclusively from the subtelomeric VSG expression sites (ESs) to evade the host immune response. Similarly, a number of other eukaryotic pathogens that undergo antigenic variation also express their major surface antigens from subtelomeres, and DNA recombination is an important means of antigen switching. Studies of T. brucei telomere biology have shown that perturbation of the telomere structure can be a double-edged sword: increasing telomere stability suppresses VSG switching, while losing gene integrity at the active VSG vicinity results in nearly 90% of cell lethality. We have shown that TRF, the duplex telomere DNA binding factor, plays important roles in maintaining telomere integrity and stability. The active VSG-adjacent telomere is transcribed by RNA Polymerase I into TERRA, which can form the telomeric R-loop (TRL) with the telomeric DNA. TRF suppresses TERRA and TRL levels, and more TRLs in TRF- depleted cells lead to more telomeric DNA damage. However, the underlying mechanisms are unclear. Homologous Recombination (HR) is a major VSG switching pathway, yet deletion of the key HR recombinase RAD51 does not eliminate recombination-mediated switching, indicating that other recombination mechanisms are involved. Microhomology-Mediated End Joining (MMEJ) events exist in T. brucei, but it is unknown whether VSG switching can occur through MMEJ. Antigenic variation is an essential pathogenesis mechanism enabling a long-term parasite infection. Understanding how telomere proteins affect VSG switching and identification of all switching pathways will help us develop means to eradicate this parasite in the future. To better understand how telomere proteins affect VSG switching and to identify additional recombination mechanisms involved in antigenic variation, we will investigate how TRF helps maintain telomere integrity and stability using novel single-molecule analyses – Atomic Force Microscopy imaging (AFM, in air and high-speed in liquids) and DNA tightropes – and genetic and molecular tools through the following aims. In Aim 1, we will examine how TRF suppresses TRL by testing whether TRF binds TRL directly and whether TRF can recruit TERRA to the duplex telomeric DNA by binding to both nucleic acids through different TRF molecules and homodimerization. We will also examine the TERRA localization and R-loop levels in TRF point mutants that weaken or enhance its TERRA binding activity. In Aim 2, we will take advantage that TRF-depleted cells have more recombination products and examine whether HR and MMEJ contribute to telomeric/ subtelomeric instability by deleting/knockdown factors essential for these pathways in TRF RNAi cells. We will then examine VSG switching in cells lacking key recombination players in the WT TRF background. Our studies will reveal how TRF maintains telomere integrity and identify potential additional important factors in antigenic variation.

项目摘要/摘要 布氏锥虫、克氏锥虫和利什曼原虫是关系密切的动体寄生虫 导致人类衰弱的疾病。布氏毛滴虫依次表达免疫不同的变异体表面 糖蛋白(VSG)是其主要的表面抗原，仅见于VSG的亚端粒表达位点(Ess)。 以逃避宿主的免疫反应。同样，一些其他真核病原体经历了抗原性 变异还表达其主要的端粒下表面抗原，而DNA重组是一个重要的 抗原转换的手段。布鲁氏毛滴虫端粒生物学的研究表明，端粒的扰动 结构可能是一把双刃剑：端粒稳定性的增加抑制了VSG的开关，同时失去了 活性VSG附近的基因完整性导致了近90%的细胞死亡。我们已经证明，扶轮基金会、 双链端粒DNA结合因子在维持端粒完整性和稳定性方面起着重要作用。这个 活性VSG相邻的端粒被RNA聚合酶I转录成Terra，从而形成端粒 R-环(TRL)与端粒DNA。TRF抑制Terra和TRL水平，TRF中更多的TRL- 耗尽的细胞会导致更多的端粒DNA损伤。然而，潜在的机制尚不清楚。 同源重组(HR)是VSG转换的主要途径，但关键的HR重组酶缺失 RAD51不能消除重组介导的开关，这表明其他重组机制 都牵涉其中。在布氏锥虫中存在微同源介导的末端连接(MMEJ)事件，但尚不清楚是否 VSG切换可以通过MMEJ进行。抗原变异是一种重要的发病机制 一种长期的寄生虫感染。了解端粒蛋白如何影响VSG开关和识别 所有的转换途径将帮助我们开发出在未来根除这种寄生虫的方法。 为了更好地了解端粒蛋白如何影响VSG开关并确定其他重组 参与抗原变异的机制，我们将研究TRF如何帮助维持端粒完整性和 利用新型单分子分析-原子力显微镜成像(AFM)在空气和高速下的稳定性 在液体中)和DNA钢丝--以及通过以下目的的遗传和分子工具。在目标1中，我们将 通过测试TRF是否直接与TRL结合以及TRF是否可以招募 Terra通过不同的TRF分子与两种核酸结合而与双链端粒DNA结合 同质二聚化。我们还将检查TRF点突变中的Terra定位和R-loop水平 削弱或增强其Terra结合活性。在目标2中，我们将利用TRF耗尽的细胞具有 更多的重组产物，并检查HR和MMEJ是否有助于端粒/亚端粒 在TRF RNAi细胞中，通过删除/敲除这些通路所必需的因子来实现不稳定性。然后我们将检查 在WT TRF背景下，VSG在缺乏关键重组参与者的细胞中切换。我们的研究将揭示 TRF如何维持端粒的完整性，并确定在抗原变异中潜在的其他重要因素。